Healthcare Horizon Hub’s Post

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure:-https://lnkd.in/dngpwpy4 The size of global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Merck Agilent Technologies Novozymes Ginkgo Bioworks, Inc. Amyris Precigen, GenScript Twist Bioscience Synthetic Genomics Vaccines Inc Codexis, Inc. Synthego Corporation Creative Enzymes Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio Cellectis Zymergen Synthego Corporation Intrexon Corporation DNA Script Arbor Biotechnologies CRISPR Therapeutics Evolva Synthetic Biology Australasia Benchling Beam Therapeutics Joyn Bio Aether Eligo Bioscience Arcturus Therapeutics Inscripta, Inc. Moderna PlasmidFactory GmbH - The Minicircle Company Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group Leaf Expression Systems Oxford Biomedica Editas Medicine #syntheticbiology #biotech #geneticengineering #crispr

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure:-https://lnkd.in/dCbcuted The size of global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Merck Agilent Technologies Novozymes Ginkgo Bioworks, Inc. Amyris Precigen, GenScript Twist Bioscience Synthetic Genomics Vaccines Inc Codexis, Inc. Synthego Corporation Creative Enzymes Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio Cellectis Zymergen Synthego Corporation Intrexon Corporation DNA Script Arbor Biotechnologies CRISPR Therapeutics Evolva Synthetic Biology Australasia Benchling Beam Therapeutics Joyn Bio Aether Eligo Bioscience Arcturus Therapeutics Inscripta, Inc. Moderna PlasmidFactory GmbH - The Minicircle Company Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group Leaf Expression Systems Oxford Biomedica Editas Medicine #syntheticbiology #biotech #geneticengineering #crispr

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure: https://lnkd.in/dcMCBsVv The size of global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific,  Merck Agilent Technologies  Novozymes  Ginkgo Bioworks, Inc.  Amyris Precigen GenScript Twist Bioscience  Synthetic Genomics Vaccines Inc  Codexis, Inc.  Synthego Corporation  Creative Enzymes  Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio  Cellectis Zymergen  Synthego Corporation  Intrexon Corporation  DNA Script Arbor Biotechnologies  CRISPR Therapeutics  Evolva Synthetic Biology Australasia  Benchling Beam Therapeutics  Joyn Bio  Aether  Eligo Bioscience  Arcturus Therapeutics  Inscripta, Inc. .  Moderna  PlasmidFactory GmbH - The Minicircle Company  Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group  Leaf Expression Systems  Oxford Biomedica  Editas Medicine #syntheticbiology #biotech #geneticengineering #crispr

Synthetic Biology Market worth $35.7 billion by 2027 Download PDF Brochure: https://lnkd.in/dYRNscVS The size of global #syntheticbiology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific, Merck Group Agilent Technologies Novozymes Ginkgo Bioworks, Inc. Amyris Precigen, GenScript Twist Bioscience Synthetic Genomics Vaccines Inc Codexis, Inc. Synthego Corporation Creative Enzymes Eurofins Scientific Finland Oy 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Arzeda bluebird bio Cellectis Zymergen Synthego Corporation Intrexon Corporation DNA Script Arbor Biotechnologies CRISPR Therapeutics Evolva Synthetic Biology Australasia Benchling Beam Therapeutics Joyn Bio Aether Eligo Bioscience Arcturus Therapeutics Inscripta, Inc. Moderna PlasmidFactory GmbH - The Minicircle Company Locus Biosciences, Inc. EnzymeWorks, Inc. Aptamer Group Leaf Expression Systems Oxford Biomedica Editas Medicine #syntheticbiology #synbio #biotechnology #geneticengineering #bioinnovation

𝐁𝐞𝐧𝐜𝐡𝐭𝐨𝐩 𝐃𝐍𝐀 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐳𝐞𝐫𝐬 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 ➡ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dxW_KqmP The DNA synthesizer market's growth is attributed to the increasing demand for efficient DNA synthesizers from life science laboratories, pharmaceutical and biotechnology companies. Advancements in genomics and life sciences and the rising importance of DNA synthesizers in synthetic and molecular biology are also driving market expansion. Furthermore, the demand for novel synthesis technologies, technological advancements, and the rise in demand for benchtop DNA synthesizers are significant factors contributing to the growth of the global market. ▪ 𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐃𝐍𝐀 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐳𝐞𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐚𝐫𝐞: ▪ Danaher Corporation ▪ Twist Bioscience ▪ Kilobaser ▪ LGC ▪ CSBio ▪ K&A Labs GmBH ▪ DNA Script ▪ Oligomer Biotechnology ▪ PolyGene AG ▪ Biolytic Lab Performance, Inc. #DNASynthesizer #Genomics #LifeSciences #MolecularBiology #DNASequencing #Biotechnology #SyntheticBiology #DNAResearch 

𝗱𝗡𝗧𝗣 𝗠𝗶𝘅 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 𝗼𝗿 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻: https://lnkd.in/d-urdatZ This report provides a comprehensive analysis of the global dNTP Mix market, including sales, revenue, and pricing trends from 2019 to 2023, along with projections for 2024 and CAGR estimates through 2030. It highlights the key producers of dNTP Mix, focusing on sales across major regions and countries, such as the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, and others. The report explores market potential, regional analysis, and identifies key stakeholders, offering insights into the competitive landscape and market positioning of leading manufacturers. This analysis aids stakeholders in understanding market dynamics and refining their strategies for future growth. *𝗕𝘆 𝗧𝘆𝗽𝗲: 10mM, 25mM, 100mM, Others *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Molecular Biology, Genomics, Pharmaceutical *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Thermo Fisher Scientific, Canvax, MyBioSource, Bio-Rad Laboratories, R&D Systems, QIAGEN, G-Biosciences, Biomatik Corporation, PCR Biosystems, AAT Bioquest, Roche, New England Biolabs, Promega Corporation , Solis BioDyne, BIORON GmbH, Zymo Research Corp, GENEON, YEASEN BIOTECHNOLOGY , Benchmark, Eurogentec #dNTPMix #DNASequencing #PolymeraseChainReaction #MolecularBiology #PCRReagents #DNAAmplification #ReverseTranscription #GeneticResearch #Genomics #DeoxynucleosideTriphosphates #dATP #dTTP #dGTP #dCTP #DNAAnalysis #GeneExpression #LabReagents #Biotechnology #ResearchTools #MolecularDiagnostics

𝗢𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report offers a comprehensive overview of the Oligonucleotide industry chain, assessing the market status of Gene Chip (DNA, RNA) and Electrophoresis (DNA, RNA), alongside key enterprises in both developed and developing markets. It analyzes cutting-edge technology, patents, hot applications, and market trends within the Oligonucleotide sector. Regionally, the report conducts thorough analyses of Oligonucleotide markets in key regions, noting steady growth in North America and Europe driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global market with robust domestic demand, supportive policies, and a strong manufacturing base. The Oligonucleotide market is segmented by Type and Application, providing accurate calculations and forecasts for consumption value by both parameters from 2024 to 2031, thus offering valuable insights for businesses targeting specific niche markets. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗢𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dQu9cs4t *𝗕𝘆 𝗧𝘆𝗽𝗲: DNA, RNA *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Gene Chip, Electrophoresis, Fluorescence In Situ Hybridization *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Abbott, PerkinElmer, SciGene Corporation, Roche NimbleGen Inc., Oligo Factory, Danaher Corporation, Thermo Fisher Scientific, GE Renewable Energy, Merck Group, Eurofins Scientific Finland Oy, Agilent Technologies, Sumitomo Chemical India Ltd, Bachem, SYLENTIS #oligonucleotide #molecularbiology #biotechnology #genetics #dnaanalysis #researchanddevelopment #genomicresearch #biotechindustry #medicalresearch #dnatechnology #healthcare #biochemistry #dnasequencing #rnaanalysis #biomedicalscience #genomicmedicine #healthinnovation #molecularmedicine #lifesciences #medicaltechnology #geneticengineering #genomicsequencing #dnaresearch #biotechresearch #healthtech #pharmaceuticals #oligosequencing #medicaldiagnostics #genetictesting #scientificresearch

𝗢𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report offers a comprehensive overview of the Oligonucleotide industry chain, assessing the market status of Gene Chip (DNA, RNA) and Electrophoresis (DNA, RNA), alongside key enterprises in both developed and developing markets. It analyzes cutting-edge technology, patents, hot applications, and market trends within the Oligonucleotide sector. Regionally, the report conducts thorough analyses of Oligonucleotide markets in key regions, noting steady growth in North America and Europe driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global market with robust domestic demand, supportive policies, and a strong manufacturing base. The Oligonucleotide market is segmented by Type and Application, providing accurate calculations and forecasts for consumption value by both parameters from 2024 to 2031, thus offering valuable insights for businesses targeting specific niche markets. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗢𝗹𝗶𝗴𝗼𝗻𝘂𝗰𝗹𝗲𝗼𝘁𝗶𝗱𝗲 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dQu9cs4t *𝗕𝘆 𝗧𝘆𝗽𝗲: DNA, RNA *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Gene Chip, Electrophoresis, Fluorescence In Situ Hybridization *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Abbott, PerkinElmer, SciGene Corporation, Roche NimbleGen Inc., Oligo Factory, Danaher Corporation, Thermo Fisher Scientific, GE Renewable Energy, Merck Group, Eurofins Scientific Finland Oy, Agilent Technologies, Sumitomo Chemical India Ltd, Bachem, SYLENTIS #oligonucleotide #molecularbiology #biotechnology #genetics #dnaanalysis #researchanddevelopment #genomicresearch #biotechindustry #medicalresearch #dnatechnology #healthcare #biochemistry #dnasequencing #rnaanalysis #biomedicalscience #genomicmedicine #healthinnovation #molecularmedicine #lifesciences #medicaltechnology #geneticengineering #genomicsequencing #dnaresearch #biotechresearch #healthtech #pharmaceuticals #oligosequencing #medicaldiagnostics #genetictesting #scientificresearch